TGF-2 and TGF-3 from cultured -amyloid-treated or 3xTg-AD-derived astrocytes may mediate astrocyte-neuron communication

Astrocytes participate in the development and resolution of neuroinflammation in numerous ways, including the release of cytokines and growth factors. Among many, astrocytes release transforming growth factors beta (TGF-) TGF-1, TGF-2 and TGF-3. TGF-1 is the most studied isoform, while production and release of TGF-2 and TGF-3 by astrocytes have been poorly characterized. Here, we report that purified cultures of hippocampal astrocytes produce mainly TGF-3 followed by TGF-2 and TGF-1. Furthermore, astrocytes release principally the active form of TGF-3 over the other two. Changes in release of TGF- were sensitive to the calcineurin (CaN) inhibitor FK506. Starvation had no effect on TGF-1 and TGF-3 while TGF-2 mRNA was significantly up-regulated in a CaN-dependent manner. We further investigated production and release of astroglial TGF- in Alzheimer's disease-related conditions. Oligomeric -amyloid (A) down-regulated TGF-1, while up-regulating TGF-2 and TGF-3, in a CaN-dependent manner. In cultured hippocampal astrocytes from 3xTg-AD mice, TGF-2 and TGF-3, but not TGF-1, were up-regulated, and this was CaN-independent. In hippocampal tissues from symptomatic 3xTg-AD mice, TGF-2 was up-regulated with respect to control mice. Finally, treatment with recombinant TGF-s showed that TGF-2 and TGF-3 significantly reduced PSD95 protein in cultured hippocampal neurons, and this effect was paralleled by conditioned media from A-treated astrocytes or from astrocytes from 3xTg-AD mice. Taken together, our data suggest that TGF-2 and TGF-3 are produced by astrocytes in a CaN-dependent manner and should be investigated further in the context of astrocyte-mediated neurodegeneration.